The Company develops, manufactures, sells and markets minimally invasive therapies for the treatment of cardiovascular disease.


Updates from The Motley Fool

Latest updates on Endologix from Fool.com.


Stock Performance

ELGX vs. S&P 500 | 2 Year Performance
View Interactive ELGX Charts
Sponsored by

Key Data Points

Primary metrics and data points about Endologix.
Current Price: $11.63
Prev Close: $11.55
Open: $11.53
Bid: $11.32
Ask: $12.00
Day's Range: $11.40 - $11.90
52wk Range: $6.50 - $14.50
Volume: 408,389
Avg Vol 1,133,354
Market Cap: $788.39M
P/E (ttm): -6.31
EPS (ttm): -$1.83
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Endologix.
CAPS Rating 3 out of 5
 
59 Outperform
12 Underperform
CAPS All Stars
 
16 Outperform
5 Underperform

How do you think Endologix will perform against the market?



You pick for Endologix is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

John McDermott, CEO

65% Approve

Based on 15 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Endologix.

The Company develops, manufactures, sells and markets minimally invasive therapies for the treatment of cardiovascular disease.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Healthcare IT